Inisia (Ulipristal acetate Tablet) 5mg

Inisia (ulipristal acetate 5mg) is an oral tablet used for emergency contraception and symptom relief in uterine fibroids. This progestin-based medication offers a non-invasive option for reproductive health needs. Suitable for adults seeking post-coital or fibroid management solutions.

Strength

5mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

HRA pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ulipristal acetate 5mg tablets like Inisia are primarily used for emergency contraception when taken within 120 hours of unprotected intercourse. They may also provide symptom relief for heavy menstrual bleeding associated with uterine fibroids in premenopausal women. The medication works by delaying ovulation and altering endometrial lining development.

Side Effects

After taking Inisia, some users may experience mild gastrointestinal effects such as nausea or abdominal discomfort. Headaches and breast tenderness are also reported by a small percentage of users. These effects are generally temporary and resolve without intervention.

Precautions & Warnings

Store Inisia at room temperature away from moisture and direct light. Keep out of reach of children and pets. If you are pregnant, breastfeeding, or have severe liver conditions, consult a healthcare provider before use. Always follow the provided instructions for safe handling.

Avoid Interactions

Inisia may interact with hormonal contraceptives, CYP3A4 inducers like rifampin, or medications affecting liver enzymes. Grapefruit juice could potentially alter its metabolism. Discuss all current medications with a healthcare professional to avoid unintended interactions.

Frequently Asked Questions

It is used for emergency contraception within 120 hours of unprotected sex and may help manage heavy bleeding from uterine fibroids.

Store at room temperature away from moisture and light, keeping them out of reach of children.

Consult a healthcare provider before combining with other drugs, as interactions are possible.

Mild nausea, headaches, and breast tenderness are occasionally reported after use.

Breastfeeding users should consult a healthcare provider before taking this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.